Literature DB >> 22344196

Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging.

Siobán D Harlow1, Margery Gass, Janet E Hall, Roger Lobo, Pauline Maki, Robert W Rebar, Sherry Sherman, Patrick M Sluss, Tobie J de Villiers.   

Abstract

OBJECTIVE: The aim of this article is to summarize the recommended updates to the 2001 Stages of Reproductive Aging Workshop (STRAW) criteria. The 2011 STRAW + 10 reviewed advances in understanding of the critical changes in hypothalamic-pituitary-ovarian function that occur before and after the final menstrual period.
METHODS: Scientists from five countries and multiple disciplines evaluated data from cohort studies of midlife women and in the context of chronic illness and endocrine disorders on change in menstrual, endocrine, and ovarian markers of reproductive aging including antimüllerian hormone, inhibin-B, follicle-stimulating hormone, and antral follicle count. Modifications were adopted by consensus.
RESULTS: STRAW + 10 simplified bleeding criteria for the early and late menopausal transition, recommended modifications to criteria for the late reproductive stage (Stage -3) and the early postmenopause stage (Stage +1), provided information on the duration of the late transition (Stage -1) and early postmenopause (Stage +1), and recommended application regardless of women's age, ethnicity, body size, or lifestyle characteristics.
CONCLUSIONS: STRAW + 10 provides a more comprehensive basis for assessing reproductive aging in research and clinical contexts. Application of the STRAW + 10 staging system should improve comparability of studies of midlife women and facilitate clinical decision making. Nonetheless, important knowledge gaps persist, and seven research priorities are identified.

Entities:  

Mesh:

Year:  2012        PMID: 22344196      PMCID: PMC3319184          DOI: 10.1210/jc.2011-3362

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  85 in total

1.  Interrelationships between ovarian and pituitary hormones in ovulatory menstrual cycles across reproductive age.

Authors:  David M Robertson; Georgina E Hale; Damien Jolley; Ian S Fraser; Claude L Hughes; Henry G Burger
Journal:  J Clin Endocrinol Metab       Date:  2008-10-14       Impact factor: 5.958

Review 2.  Anti-Müllerian hormone as a marker of ovarian reserve: an update.

Authors:  David M Robertson
Journal:  Womens Health (Lond)       Date:  2008-03

Review 3.  Ovarian aging: mechanisms and clinical consequences.

Authors:  F J Broekmans; M R Soules; B C Fauser
Journal:  Endocr Rev       Date:  2009-07-09       Impact factor: 19.871

4.  A proposed classification system for menstrual cycles in the menopause transition based on changes in serum hormone profiles.

Authors:  David M Robertson; Georgina E Hale; Ian S Fraser; Claude L Hughes; Henry G Burger
Journal:  Menopause       Date:  2008 Nov-Dec       Impact factor: 2.953

5.  Factors that influence entry into stages of the menopausal transition.

Authors:  Mary D Sammel; Ellen W Freeman; Ziyue Liu; Hui Lin; Wensheng Guo
Journal:  Menopause       Date:  2009 Nov-Dec       Impact factor: 2.953

6.  Longitudinal changes in sexual functioning as women transition through menopause: results from the Study of Women's Health Across the Nation.

Authors:  Nancy E Avis; Sarah Brockwell; John F Randolph; Shunhua Shen; Virginia S Cain; Marcia Ory; Gail A Greendale
Journal:  Menopause       Date:  2009 May-Jun       Impact factor: 2.953

7.  Adipokines, inflammation, and visceral adiposity across the menopausal transition: a prospective study.

Authors:  Christine G Lee; Molly C Carr; Susan J Murdoch; Ellen Mitchell; Nancy F Woods; Mark H Wener; Wayne L Chandler; Edward J Boyko; John D Brunzell
Journal:  J Clin Endocrinol Metab       Date:  2009-01-06       Impact factor: 5.958

8.  Anti-Mullerian hormone, inhibin B, and antral follicle count in young women with ovarian failure.

Authors:  Erik A H Knauff; Marinus J C Eijkemans; Cornelius B Lambalk; Marianne J ten Kate-Booij; Annemieke Hoek; Catharina C M Beerendonk; Joop S E Laven; Angelique J Goverde; Frank J M Broekmans; Axel P N Themmen; Frank H de Jong; Bart C J M Fauser
Journal:  J Clin Endocrinol Metab       Date:  2008-12-09       Impact factor: 5.958

9.  Follicle stimulating hormone and its rate of change in defining menopause transition stages.

Authors:  MaryFran R Sowers; Huiyong Zheng; Daniel McConnell; Bin Nan; Sioban Harlow; John F Randolph
Journal:  J Clin Endocrinol Metab       Date:  2008-07-22       Impact factor: 5.958

10.  Total and unopposed estrogen exposure across stages of the transition to menopause.

Authors:  Kathleen A O'Connor; Rebecca J Ferrell; Eleanor Brindle; Jane Shofer; Darryl J Holman; Rebecca C Miller; Deborah E Schechter; Burton Singer; Maxine Weinstein
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-02-24       Impact factor: 4.254

View more
  260 in total

Review 1.  Perimenopause: From Research to Practice.

Authors:  Nanette Santoro
Journal:  J Womens Health (Larchmt)       Date:  2015-12-10       Impact factor: 2.681

2.  Anxiety as a risk factor for menopausal hot flashes: evidence from the Penn Ovarian Aging cohort.

Authors:  Ellen W Freeman; Mary D Sammel
Journal:  Menopause       Date:  2016-09       Impact factor: 2.953

Review 3.  Bipolar Disorder in the Menopausal Transition.

Authors:  Dawn Truong; Wendy Marsh
Journal:  Curr Psychiatry Rep       Date:  2019-11-25       Impact factor: 5.285

4.  Follicle stimulating hormone, its novel association with sex hormone binding globulin in men and postmenopausal women.

Authors:  Ningjian Wang; Kun Zhang; Bing Han; Qin Li; Yi Chen; Chunfang Zhu; Yingchao Chen; Fangzhen Xia; Hualing Zhai; Boren Jiang; Zhoujun Shen; Yingli Lu
Journal:  Endocrine       Date:  2017-03-04       Impact factor: 3.633

5.  Lifelong estradiol exposure and risk of depressive symptoms during the transition to menopause and postmenopause.

Authors:  Wendy K Marsh; Joyce T Bromberger; Sybil L Crawford; Katherine Leung; Howard M Kravitz; John F Randolph; Hadine Joffe; Claudio N Soares
Journal:  Menopause       Date:  2017-12       Impact factor: 2.953

6.  Noncalcified coronary atherosclerotic plaque and immune activation in HIV-infected women.

Authors:  Kathleen V Fitch; Suman Srinivasa; Suhny Abbara; Tricia H Burdo; Kenneth C Williams; Peace Eneh; Janet Lo; Steven K Grinspoon
Journal:  J Infect Dis       Date:  2013-09-16       Impact factor: 5.226

7.  Hypoglycosylated hFSH Has Greater Bioactivity Than Fully Glycosylated Recombinant hFSH in Human Granulosa Cells.

Authors:  Chao Jiang; Xiaoying Hou; Cheng Wang; Jeffrey V May; Viktor Y Butnev; George R Bousfield; John S Davis
Journal:  J Clin Endocrinol Metab       Date:  2015-04-27       Impact factor: 5.958

8.  Menopausal hot flashes and the default mode network.

Authors:  Rebecca C Thurston; Pauline M Maki; Carol A Derby; Ervin Sejdić; Howard J Aizenstein
Journal:  Fertil Steril       Date:  2015-04-22       Impact factor: 7.329

9.  Anti-Müllerian hormone deficiency in females with Fanconi anemia.

Authors:  Martha M Sklavos; Neelam Giri; Pamela Stratton; Blanche P Alter; Ligia A Pinto
Journal:  J Clin Endocrinol Metab       Date:  2014-01-17       Impact factor: 5.958

Review 10.  The menopause and aging, a comparative perspective.

Authors:  Caleb E Finch
Journal:  J Steroid Biochem Mol Biol       Date:  2013-04-10       Impact factor: 4.292

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.